Cynthia S Kubu1, Scott E Cooper2, Andre Machado2, Thomas Frazier2, Jerrold Vitek2, Paul J Ford2. 1. From the Center for Neurological Restoration (C.S.K., A.M.), Center for Pediatric Behavioral Health (T.F.), and NeuroEthics Program (P.J.F.), Cleveland Clinic, OH; and Department of Neurology (S.E.C., J.V.), University of Minnesota, Minneapolis. kubuc@ccf.org. 2. From the Center for Neurological Restoration (C.S.K., A.M.), Center for Pediatric Behavioral Health (T.F.), and NeuroEthics Program (P.J.F.), Cleveland Clinic, OH; and Department of Neurology (S.E.C., J.V.), University of Minnesota, Minneapolis.
Abstract
OBJECTIVE: To report prospective repeated measures data detailing the perceived benefit of deep brain stimulation (DBS) on the most commonly cited symptom and activity goals identified by patients with Parkinson disease. METHODS: Fifty-two participants were recruited from a consecutive series. Participants completed a semi-structured interview soliciting their symptom and behavioral goals and corresponding visual analog scales measuring perceived symptom severity and limits to goal attainment. Severity ratings were completed prior to and at 2 times following DBS. Changes in severity over time were assessed using a mixed effects linear model. The pattern of relationships between the severity ratings and standard clinical research (SCR) measures routinely administered were examined using Pearson correlations. RESULTS: The most common symptom goals were improvements in tremor, gait, and nonmotor symptoms, whereas the most frequent behavioral goals related to interpersonal relationships, work, and avocational pursuits. Most severity ratings were significantly correlated with each other but not with the SCR measures. Significant improvements were evident on all SCR measures after DBS. Participants' severity ratings for their symptom and behavioral goals improved significantly over time although not all severity ratings changed in the same manner. CONCLUSIONS: These data illustrate that improvements in participants' individually defined goals were evident over time and that some of these improvements occurred in areas in which the benefits associated with DBS are not as well-documented. The participants' severity ratings were not redundant with SCR measures, suggesting that novel and potentially important information can be gleaned by systematically assessing patients' goals.
OBJECTIVE: To report prospective repeated measures data detailing the perceived benefit of deep brain stimulation (DBS) on the most commonly cited symptom and activity goals identified by patients with Parkinson disease. METHODS: Fifty-two participants were recruited from a consecutive series. Participants completed a semi-structured interview soliciting their symptom and behavioral goals and corresponding visual analog scales measuring perceived symptom severity and limits to goal attainment. Severity ratings were completed prior to and at 2 times following DBS. Changes in severity over time were assessed using a mixed effects linear model. The pattern of relationships between the severity ratings and standard clinical research (SCR) measures routinely administered were examined using Pearson correlations. RESULTS: The most common symptom goals were improvements in tremor, gait, and nonmotor symptoms, whereas the most frequent behavioral goals related to interpersonal relationships, work, and avocational pursuits. Most severity ratings were significantly correlated with each other but not with the SCR measures. Significant improvements were evident on all SCR measures after DBS. Participants' severity ratings for their symptom and behavioral goals improved significantly over time although not all severity ratings changed in the same manner. CONCLUSIONS: These data illustrate that improvements in participants' individually defined goals were evident over time and that some of these improvements occurred in areas in which the benefits associated with DBS are not as well-documented. The participants' severity ratings were not redundant with SCR measures, suggesting that novel and potentially important information can be gleaned by systematically assessing patients' goals.
Authors: Günther Deuschl; Carmen Schade-Brittinger; Paul Krack; Jens Volkmann; Helmut Schäfer; Kai Bötzel; Christine Daniels; Angela Deutschländer; Ulrich Dillmann; Wilhelm Eisner; Doreen Gruber; Wolfgang Hamel; Jan Herzog; Rüdiger Hilker; Stephan Klebe; Manja Kloss; Jan Koy; Martin Krause; Andreas Kupsch; Delia Lorenz; Stefan Lorenzl; H Maximilian Mehdorn; Jean Richard Moringlane; Wolfgang Oertel; Marcus O Pinsker; Heinz Reichmann; Alexander Reuss; Gerd-Helge Schneider; Alfons Schnitzler; Ulrich Steude; Volker Sturm; Lars Timmermann; Volker Tronnier; Thomas Trottenberg; Lars Wojtecki; Elisabeth Wolf; Werner Poewe; Jürgen Voges Journal: N Engl J Med Date: 2006-08-31 Impact factor: 91.245
Authors: M Schüpbach; M Gargiulo; M L Welter; L Mallet; C Béhar; J L Houeto; D Maltête; V Mesnage; Y Agid Journal: Neurology Date: 2006-06-27 Impact factor: 9.910
Authors: Michael S Okun; Ramon L Rodriguez; Ania Mikos; Kimberly Miller; Ida Kellison; Lindsey Kirsch-Darrow; Dylan P Wint; Utaka Springer; Hubert H Fernandez; Kelly D Foote; Gregory Crucian; Dawn Bowers Journal: Clin Neuropsychol Date: 2007-01 Impact factor: 3.535
Authors: Frances M Weaver; Kenneth Follett; Matthew Stern; Kwan Hur; Crystal Harris; William J Marks; Johannes Rothlind; Oren Sagher; Domenic Reda; Claudia S Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff Bronstein; Gatana Stoner; Jill Heemskerk; Grant D Huang Journal: JAMA Date: 2009-01-07 Impact factor: 56.272
Authors: Amanda R Merner; Thomas Frazier; Paul J Ford; Scott E Cooper; Andre Machado; Brittany Lapin; Jerrold Vitek; Cynthia S Kubu Journal: Front Hum Neurosci Date: 2021-02-24 Impact factor: 3.169
Authors: Cynthia S Kubu; Thomas Frazier; Scott E Cooper; Andre Machado; Jerrold Vitek; Paul J Ford Journal: Neurology Date: 2018-06-29 Impact factor: 9.910
Authors: Hendriekje Eggink; Rivka F Toonen; Jonathan C van Zijl; Martje E van Egmond; Anna L Bartels; Rick Brandsma; M Fiorella Contarino; Kathryn J Peall; J Marc C van Dijk; D L Marinus Oterdoom; Martijn Beudel; Marina A J Tijssen Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2020-06-08
Authors: Adolfo Ramirez-Zamora; James Giordano; Aysegul Gunduz; Jose Alcantara; Jackson N Cagle; Stephanie Cernera; Parker Difuntorum; Robert S Eisinger; Julieth Gomez; Sarah Long; Brandon Parks; Joshua K Wong; Shannon Chiu; Bhavana Patel; Warren M Grill; Harrison C Walker; Simon J Little; Ro'ee Gilron; Gerd Tinkhauser; Wesley Thevathasan; Nicholas C Sinclair; Andres M Lozano; Thomas Foltynie; Alfonso Fasano; Sameer A Sheth; Katherine Scangos; Terence D Sanger; Jonathan Miller; Audrey C Brumback; Priya Rajasethupathy; Cameron McIntyre; Leslie Schlachter; Nanthia Suthana; Cynthia Kubu; Lauren R Sankary; Karen Herrera-Ferrá; Steven Goetz; Binith Cheeran; G Karl Steinke; Christopher Hess; Leonardo Almeida; Wissam Deeb; Kelly D Foote; Michael S Okun Journal: Front Hum Neurosci Date: 2020-03-27 Impact factor: 3.169
Authors: Liesanne M Centen; D L Marinus Oterdoom; Marina A J Tijssen; Ivon Lesman-Leegte; Martje E van Egmond; J Marc C van Dijk Journal: Mov Disord Date: 2020-11-20 Impact factor: 10.338